CLINICAL_TRIALS
trial_result
· 2013-12-10
Clinical Trial Update: A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal Infection [Phase 3]
Summary
Pfizer-sponsored Phase 3 study of intravenous metronidazole for intra-abdominal infections has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Intra-abdominal Infections | Phase 3 | Status: COMPLETED | Results posted: 2013-12-10